{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:40:39Z","timestamp":1773218439665,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T00:00:00Z","timestamp":1442620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10620-015-3869-4","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:16:56Z","timestamp":1444263416000},"page":"238-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Reduced Risk of Barrett\u2019s Esophagus in Statin Users: Case\u2013Control Study and Meta-Analysis"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1923-3237","authenticated-orcid":false,"given":"Ian L. P.","family":"Beales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Dearman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Vardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon","family":"Loke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,19]]},"reference":[{"key":"3869_CR1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/jnci\/djn211","volume":"100","author":"LM Brown","year":"2008","unstructured":"Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184\u20131187.","journal-title":"J Natl Cancer Inst"},{"key":"3869_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10552-007-9000-1","volume":"18","author":"X Wu","year":"2007","unstructured":"Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control. 2007;18:585\u2013593.","journal-title":"Cancer Causes Control"},{"key":"3869_CR3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4291\/wjgp.v5.i4.534","volume":"5","author":"L Alexandre","year":"2014","unstructured":"Alexandre L, Long E, Beales IL. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol. 2014;5:534\u2013549.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"3869_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756283X14538689","volume":"7","author":"E Long","year":"2014","unstructured":"Long E, Beales IL. The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol. 2014;7:247\u2013268.","journal-title":"Therap Adv Gastroenterol"},{"key":"3869_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","volume":"8","author":"M Sikkema","year":"2010","unstructured":"Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235\u2013244.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3869_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwn121","volume":"168","author":"F Yousef","year":"2008","unstructured":"Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett\u2019s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237\u2013249.","journal-title":"Am J Epidemiol"},{"key":"3869_CR7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/gutjnl-2011-300730","volume":"61","author":"TK Desai","year":"2012","unstructured":"Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett\u2019s oesophagus: a meta-analysis. Gut. 2012;61:970\u2013976.","journal-title":"Gut"},{"key":"3869_CR8","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2011.04.061","volume":"141","author":"NJ Shaheen","year":"2011","unstructured":"Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett\u2019s esophagus with dysplasia. Gastroenterology. 2011;141:460\u2013468.","journal-title":"Gastroenterology"},{"key":"3869_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/JTO.0b013e3182397751","volume":"7","author":"A Dubecz","year":"2012","unstructured":"Dubecz A, Gall I, Solymosi N, et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J Thorac Oncol. 2012;7:443\u2013447.","journal-title":"J Thorac Oncol"},{"key":"3869_CR10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1572-0241.2007.01773.x","volume":"103","author":"OO Ogunwobi","year":"2008","unstructured":"Ogunwobi OO, Beales IL. Statins inhibit proliferation and induce apoptosis in barrett\u2019s esophageal adenocarcinoma cells. Am J Gastroenterol. 2008;103:825\u2013837.","journal-title":"Am J Gastroenterol"},{"key":"3869_CR11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.2011.06053.x","volume":"1232","author":"D Fang","year":"2011","unstructured":"Fang D, Das KM, Cao W, et al. Barrett\u2019s esophagus: progression to adenocarcinoma and markers. Ann N Y Acad Sci. 2011;1232:210\u2013229.","journal-title":"Ann N Y Acad Sci"},{"key":"3869_CR12","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/ijc.24875","volume":"126","author":"IL Beales","year":"2010","unstructured":"Beales IL, Ogunwobi OO. Microsomal prostaglandin E synthase-1 inhibition blocks proliferation and enhances apoptosis in oesophageal adenocarcinoma cells without affecting endothelial prostacyclin production. Int J Cancer. 2010;126:2247\u20132255.","journal-title":"Int J Cancer"},{"key":"3869_CR13","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1053\/j.gastro.2011.08.036","volume":"141","author":"F Kastelein","year":"2011","unstructured":"Kastelein F, Spaander MC, Biermann K, Steyerberg EW, Kuipers EJ, Bruno MJ. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett\u2019s esophagus. Gastroenterology. 2011;141:2000\u20132008.","journal-title":"Gastroenterology"},{"key":"3869_CR14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/MEG.0b013e3283543f01","volume":"24","author":"IL Beales","year":"2012","unstructured":"Beales IL, Vardi I, Dearman L. Regular statin and aspirin use in patients with Barrett\u2019s oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 2012;24:917\u2013923.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3869_CR15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-2050.2012.01412.x","volume":"26","author":"I Beales","year":"2013","unstructured":"Beales I, Vardi I, Dearman L, Broughton T. Statin use is associated with a reduction in the incidence of esophageal adenoncarcinoma: a case\u2013control study. Dis Esophagus. 2013;26:838\u2013846.","journal-title":"Dis Esophagus"},{"key":"3869_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4292\/wjgpt.v4.i3.69","volume":"4","author":"IL Beales","year":"2013","unstructured":"Beales IL, Hensley A, Loke Y. Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition. World J Gastrointest Pharmacol Ther. 2013;4:69\u201379.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"3869_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh S, Singh AG, Singh PP, Murad MH, Iyer PG. Statins are associated with reduced risk of esophageal cancer, particularly in patients with barrett\u2019s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:620\u2013629.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3869_CR18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/j.gastro.2013.11.046","volume":"146","author":"L Alexandre","year":"2014","unstructured":"Alexandre L, Clark AB, Bhutta HY, Holt S, Lewis MP, Hart AR. Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case\u2013control analysis. Gastroenterology. 2014;146:661\u2013668.","journal-title":"Gastroenterology"},{"key":"3869_CR19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00384-012-1601-9","volume":"28","author":"T Broughton","year":"2013","unstructured":"Broughton T, Sington J, Beales IL. Statin use is associated with a reduced incidence of colorectal adenomatous polyps. Int J Colorectal Dis. 2013;28:469\u2013476.","journal-title":"Int J Colorectal Dis"},{"key":"3869_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1442-2050.2011.01285.x","volume":"25","author":"L Alexandre","year":"2012","unstructured":"Alexandre L, Broughton T, Loke Y, Beales IL. Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter. Dis Esophagus. 2012;25:535\u2013544.","journal-title":"Dis Esophagus"},{"key":"3869_CR21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.gastro.2014.04.040","volume":"147","author":"T Nguyen","year":"2014","unstructured":"Nguyen T, Khalaf N, Ramsey D, El-Serag HB. Statin use is associated with a decreased risk of Barrett\u2019s esophagus. Gastroenterology. 2014;147:314\u2013323.","journal-title":"Gastroenterology"},{"key":"3869_CR22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cgh.2012.02.031","volume":"10","author":"ZB Omer","year":"2012","unstructured":"Omer ZB, Ananthakrishnan AN, Nattinger KJ, et al. Aspirin protects against Barrett\u2019s esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012;10:722\u2013727.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3869_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-230X-12-36","volume":"12","author":"T Broughton","year":"2012","unstructured":"Broughton T, Sington J, Beales IL. Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case\u2013control study. BMC Gastroenterol. 2012;12:36.","journal-title":"BMC Gastroenterol"},{"key":"3869_CR24","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/2050640613504917","volume":"1","author":"G Balasubramanian","year":"2013","unstructured":"Balasubramanian G, Gupta N, Giacchino M, et al. Cigarette smoking is a modifiable risk factor for Barrett\u2019s oesophagus. United European Gastroenterol J. 2013;1:430\u2013437.","journal-title":"United European Gastroenterol J"},{"key":"3869_CR25","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/gut.2008.174508","volume":"58","author":"BC Jacobson","year":"2009","unstructured":"Jacobson BC, Chan AT, Giovannucci EL, Fuchs CS. Body mass index and Barrett\u2019s oesophagus in women. Gut. 2009;58:1460\u20131466.","journal-title":"Gut"},{"key":"3869_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/gutjnl-2012-304103","volume":"63","author":"JH Rubenstein","year":"2014","unstructured":"Rubenstein JH, Morgenstern H, Chey WD, et al. Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett\u2019s oesophagus. Gut. 2014;63:230\u2013235.","journal-title":"Gut"},{"key":"3869_CR27","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","volume":"138","author":"DM Nguyen","year":"2010","unstructured":"Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus. Gastroenterology. 2010;138:2260\u20132266.","journal-title":"Gastroenterology"},{"key":"3869_CR28","doi-asserted-by":"crossref","first-page":"e006640","DOI":"10.1136\/bmjopen-2014-006640","volume":"5","author":"GM Masclee","year":"2015","unstructured":"Masclee GM, Coloma PM, Spaander MC, Kuipers EJ, Sturkenboom MC. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett\u2019s oesophagus: a population-based case\u2013control study. BMJ Open. 2015;5:e006640.","journal-title":"BMJ Open"},{"key":"3869_CR29","first-page":"463","volume":"33","author":"K Yokota","year":"2006","unstructured":"Yokota K, Miyazaki T, Hirano M, Akiyama Y, Mimura T. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol. 2006;33:463\u2013471.","journal-title":"J Rheumatol"},{"key":"3869_CR30","first-page":"696","volume":"25","author":"PE Lazzerini","year":"2007","unstructured":"Lazzerini PE, Lorenzini S, Selvi E, et al. Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol. 2007;25:696\u2013700.","journal-title":"Clin Exp Rheumatol"},{"key":"3869_CR31","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/ajg.2013.222","volume":"108","author":"D Lin","year":"2013","unstructured":"Lin D, Kramer JR, Ramsey D, et al. Oral bisphosphonates and the risk of Barrett\u2019s esophagus: case\u2013control analysis of US veterans. Am J Gastroenterol. 2013;108:1576\u20131583.","journal-title":"Am J Gastroenterol"},{"key":"3869_CR32","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1007\/s10620-015-3569-0","volume":"60","author":"A Goldberg","year":"2015","unstructured":"Goldberg A, Gerkin RD, Young M. Medical Prevention of Barrett\u2019s esophagus: effects of statins, aspirin, non-aspirin NSAIDs, calcium, and multivitamins. Dig Dis Sci. 2015;60:2058\u20132062.","journal-title":"Dig Dis Sci"},{"key":"3869_CR33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2036.2011.04855.x","volume":"34","author":"AP Thrift","year":"2011","unstructured":"Thrift AP, Pandeya N, Smith KJ, Green AC, Webb PM, Whiteman DC. The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett\u2019s oesophagus. Aliment Pharmacol Ther. 2011;34:1235\u20131244.","journal-title":"Aliment Pharmacol Ther"},{"key":"3869_CR34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2036.2003.01432.x","volume":"17","author":"E Cheong","year":"2003","unstructured":"Cheong E, Igali L, Harvey I, et al. Cyclo-oxygenase-2 expression in Barrett\u2019s oesophageal carcinogenesis: an immunohistochemical study. Aliment Pharmacol Ther. 2003;17:379\u2013386.","journal-title":"Aliment Pharmacol Ther"},{"key":"3869_CR35","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/bjc.2014.473","volume":"111","author":"TV Macfarlane","year":"2014","unstructured":"Macfarlane TV, Lefevre K, Watson MC. Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer. Br J Cancer. 2014;111:1852\u20131859.","journal-title":"Br J Cancer"},{"key":"3869_CR36","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/bjc.2014.127","volume":"110","author":"S Zhang","year":"2014","unstructured":"Zhang S, Zhang XQ, Ding XW, et al. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus: a meta-analysis. Br J Cancer. 2014;110:2378\u20132388.","journal-title":"Br J Cancer"},{"key":"3869_CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1751-2980.12047","volume":"14","author":"N Sivarasan","year":"2013","unstructured":"Sivarasan N, Smith G. Role of aspirin in chemoprevention of esophageal adenocarcinoma: a meta-analysis. J Dig Dis. 2013;14:222\u2013230.","journal-title":"J Dig Dis"},{"key":"3869_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","volume":"191","author":"M Dovizio","year":"2013","unstructured":"Dovizio M, Bruno A, Tacconelli S, Patrignani P. Mode of action of aspirin as a chemopreventive agent. Recent Results Cancer Res. 2013;191:39\u201365.","journal-title":"Recent Results Cancer Res"},{"key":"3869_CR39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/nyas.12249","volume":"1300","author":"Y Fang","year":"2013","unstructured":"Fang Y, Chen X, Bajpai M, et al. Cellular origins and molecular mechanisms of Barrett\u2019s esophagus and esophageal adenocarcinoma. Ann N Y Acad Sci. 2013;1300:187\u2013199.","journal-title":"Ann N Y Acad Sci"},{"key":"3869_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09674845.2008.11732814","volume":"65","author":"OO Ogunwobi","year":"2008","unstructured":"Ogunwobi OO, Beales IL. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor. Br J Biomed Sci. 2008;65:121\u2013127.","journal-title":"Br J Biomed Sci"},{"key":"3869_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2008.01.023","volume":"285","author":"OO Ogunwobi","year":"2008","unstructured":"Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol. 2008;285:43\u201350.","journal-title":"Mol Cell Endocrinol"},{"key":"3869_CR42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mce.2013.08.013","volume":"382","author":"IL Beales","year":"2013","unstructured":"Beales IL, Garcia-Morales C, Ogunwobi OO, Mutungi G. Adiponectin inhibits leptin-induced oncogenic signalling in oesophageal cancer cells by activation of PTP1B. Mol Cell Endocrinol. 2013;382:150\u2013158.","journal-title":"Mol Cell Endocrinol"},{"key":"3869_CR43","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/en.2006-0224","volume":"147","author":"O Ogunwobi","year":"2006","unstructured":"Ogunwobi O, Mutungi G, Beales IL. Leptin stimulates proliferation and inhibits apoptosis in Barrett\u2019s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology. 2006;147:4505\u20134516.","journal-title":"Endocrinology"},{"key":"3869_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2407-7-97","volume":"7","author":"IL Beales","year":"2007","unstructured":"Beales IL, Ogunwobi OO, Cameron E, El-Amin K, Mutungi G, Wilkinson M. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett\u2019s oesophagus and contributes to increased proliferation and inhibition of apoptosis: a functional and immunohistochemical study. BMC Cancer. 2007;7:97.","journal-title":"BMC Cancer"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3869-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3869-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3869-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T16:48:20Z","timestamp":1718124500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3869-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,19]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3869"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3869-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,19]]}}}